Literature DB >> 16150441

Propranolol inhibits the human ether-a-go-go-related gene potassium channels.

Xiaozhou Yao1, Maggie S McIntyre, Daniel G Lang, Ivy H Song, James D Becherer, Mir A Hashim.   

Abstract

Propranolol is a noncardioselective beta-adrenergic antagonist that has been recently reported to prolong the QTc interval on the surface electrocardiogram in humans when overdosed [Farhangi, V., Sansone, R.A. (2003). QTc prolongation due to propranolol overdose. Int. J. Psychiatry Med. 33, 201-202.]. To examine the underlying mechanisms for these clinical findings, we studied the effects of propranolol on the human cardiac potassium channels encoded by the ether-a-go-go-related gene (ERG) using the whole cell voltage-clamp technique. We found that propranolol blocked hERG currents in a concentration-dependent manner with an IC50 of 9.9+/-1.3 microM which is relevant to the predicted plasma level of propranolol in this case report. The present study demonstrated that propranolol can inhibit hERG channels. The interaction between propranolol and hERG channels could lead to delayed cardiac repolarization and might be a molecular mechanism for the previously reported QTc prolongation when propranolol is overdosed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16150441     DOI: 10.1016/j.ejphar.2005.05.010

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Comparison of HERG channel blocking effects of various beta-blockers-- implication for clinical strategy.

Authors:  Kazunobu Kawakami; Toshihisa Nagatomo; Haruhiko Abe; Kan Kikuchi; Hiroko Takemasa; Blake D Anson; Brian P Delisle; Craig T January; Yasuhide Nakashima
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

2.  Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3.

Authors:  John R Bankston; Robert S Kass
Journal:  J Mol Cell Cardiol       Date:  2009-05-28       Impact factor: 5.000

3.  Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model.

Authors:  X Yao; D L Anderson; S A Ross; D G Lang; B Z Desai; D C Cooper; P Wheelan; M S McIntyre; M L Bergquist; K I MacKenzie; J D Becherer; M A Hashim
Journal:  Br J Pharmacol       Date:  2008-06-30       Impact factor: 8.739

4.  The role and mechanism of chaperones Calnexin/Calreticulin in which ALLN selectively rescues the trafficking defective of HERG-A561V mutation.

Authors:  Ying Wang; Tingting Shen; Peiliang Fang; Junbo Zhou; Kenan Lou; Zemin Cen; Hai Qian; Jianqing Zhou; Ningsheng Liu; Jiangfang Lian
Journal:  Biosci Rep       Date:  2018-09-07       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.